3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
CNS
1
Conditions
Multiple Myeloma
495
Lymphoma
52
Recurrence
50
Neoplasms, Plasma Cell
49
Immunoglobulin Light-chain Amyloidosis
43
Neoplasms
35
Lymphoma, Non-Hodgkin
35
Leukemia
34
Hematologic Neoplasms
32
Myelodysplastic Syndromes
28
Smoldering Multiple Myeloma
27
Leukemia, Myeloid, Acute
26
Leukemia, Plasma Cell
23
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Monoclonal Gammopathy of Undetermined Significance
18
Hodgkin Disease
18
Leukemia, Lymphocytic, Chronic, B-Cell
17
Amyloidosis
17
Lymphoma, B-Cell
15
Breast Neoplasms
14
Ovarian Neoplasms
12
Paraproteinemias
11
Myeloproliferative Disorders
10
Colorectal Neoplasms
10
Primary Myelofibrosis
9
Melanoma
9
Lymphoma, Follicular
9
Infections
9
Prostatic Neoplasms
8
Lymphoproliferative Disorders
8
Interventions
fludarabine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Autoimmune Diseases of the Nervous System
×
Plasma cell
×
Clear all
NCT04561557
2024-10-30
CARTinNS
Tongji Hospital
Phase EARLY_PHASE1
Recruiting
36 enrolled